Company page

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States with a market capitalization of approximately $398 million. The company focuses on developing innovative therapies for rare diseases. X4 aims to address unmet medical needs through its research and development efforts.